First Analysis Upgrades Praxair To Overweight
First Analysis upgraded Praxair (NYSE: PX) from Equal-weight to Overweight.
The target price for Praxair is set to $155.
Praxair shares have surged 7.53% over the past 52 weeks, while the S&P 500 index has gained 16.87% in the same period.
Praxair's shares surged 0.42% to close at $129.22 yesterday.
Latest Ratings for PX
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2021 | Stephens & Co. | Initiates Coverage On | Overweight | |
| Nov 2021 | UBS | Initiates Coverage On | Buy | |
| Nov 2021 | Morgan Stanley | Initiates Coverage On | Overweight |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: First AnalysisUpgrades Analyst Ratings
